These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2140983)

  • 1. Role of the C-terminal region in the allosteric properties of Escherichia coli phosphofructokinase-1.
    Serre MC; Garel JR
    Eur J Biochem; 1990 May; 189(3):487-92. PubMed ID: 2140983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction by site-directed mutagenesis of a tryptophan residue as a fluorescent probe for the folding of Escherichia coli phosphofructokinase.
    Teschner W; Serre MC; Garel JR
    Biochimie; 1990; 72(6-7):403-6. PubMed ID: 2147862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific suppression of heterotropic interactions in phosphofructokinase by the mutation of leucine 178 into tryptophan.
    Serre MC; Teschner W; Garel JR
    J Biol Chem; 1990 Jul; 265(21):12146-8. PubMed ID: 2142686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and properties of the phosphofructokinase from Lactobacillus bulgaricus. A non-allosteric analog of the enzyme from Escherichia coli.
    Le Bras G; Deville-Bonne D; Garel JR
    Eur J Biochem; 1991 Jun; 198(3):683-7. PubMed ID: 1828763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing an allosterically locked phosphofructokinase.
    Kundrot CE; Evans PR
    Biochemistry; 1991 Feb; 30(6):1478-84. PubMed ID: 1825177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active-site mutants altering the cooperativity of E. coli phosphofructokinase.
    Berger SA; Evans PR
    Nature; 1990 Feb; 343(6258):575-6. PubMed ID: 2137204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cooperativity and allosteric inhibition of Escherichia coli phosphofructokinase depend on the interaction between threonine-125 and ATP.
    Auzat I; Le Bras G; Garel JR
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5242-6. PubMed ID: 8202475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric activation increases the maximum velocity of E. coli phosphofructokinase.
    Auzat I; Le Bras G; Garel JR
    J Mol Biol; 1997 Apr; 267(3):476-80. PubMed ID: 9126831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed mutagenesis identifies catalytic residues in the active site of Escherichia coli phosphofructokinase.
    Berger SA; Evans PR
    Biochemistry; 1992 Sep; 31(38):9237-42. PubMed ID: 1390710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow ligand-induced transitions in the allosteric phosphofructokinase from Escherichia coli.
    Auzat I; Gawlita E; Garel JR
    J Mol Biol; 1995 Jun; 249(2):478-92. PubMed ID: 7783204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proteolyzed derivative of Escherichia coli phosphofructokinase is no longer sensitive to allosteric effectors and still shows cooperativity in substrate binding.
    Le Bras G; Garel JR
    Biochemistry; 1982 Dec; 21(26):6656-60. PubMed ID: 6218818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH dependence of the kinetic properties of allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Bourgain F; Garel JR
    Biochemistry; 1991 Jun; 30(23):5750-4. PubMed ID: 1828369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissection of the effector-binding site and complementation studies of Escherichia coli phosphofructokinase using site-directed mutagenesis.
    Lau FT; Fersht AR
    Biochemistry; 1989 Aug; 28(17):6841-7. PubMed ID: 2531002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis of rabbit muscle phosphofructokinase cDNA. Mutations at glutamine 200 affect the allosteric properties of the enzyme.
    Li J; Zhu X; Byrnes M; Nelson JW; Chang SH
    J Biol Chem; 1993 Nov; 268(33):24599-606. PubMed ID: 8227018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conformational transition involved in antagonistic substrate binding to the allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Garel JR
    Biochemistry; 1992 Feb; 31(6):1695-700. PubMed ID: 1531298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited proteolysis at the carboxy end modifies interactions between the subunits of Escherichia coli phosphofructokinase.
    Le Bras G; Garel JR
    Biochemistry; 1986 May; 25(9):2490-3. PubMed ID: 2941077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose 6-phosphate prevents the proteolyzed derivative of Escherichia coli phosphofructokinase from dissociation and inactivation.
    Le Bras G; Garel JR
    J Biol Chem; 1985 Nov; 260(25):13450-3. PubMed ID: 2932439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and nucleotide sequence of the gene for pyruvate kinase of Bacillus stearothermophilus and the production of the enzyme in Escherichia coli. Evidence that the genes for phosphofructokinase and pyruvate kinase constitute an operon.
    Sakai H; Ohta T
    Eur J Biochem; 1993 Feb; 211(3):851-9. PubMed ID: 8436141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Escherichia coli fructose-6-phosphate kinases. Preparative purification, oligomeric structure and immunological studies.
    Kotlarz D; Buc H
    Biochim Biophys Acta; 1977 Sep; 484(1):35-48. PubMed ID: 70226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of allosteric inhibition to activation in phosphofructokinase by protein engineering.
    Lau FT; Fersht AR
    Nature; 1987 Apr 23-29; 326(6115):811-2. PubMed ID: 2952886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.